Developmental Toxicity

US Researchers Report PFDA Mechanism Disrupting Foetal Craniofacial Development

New mechanistic evidence links the long-chain PFAS perfluorodecanoic acid (PFDA) to fetal developmental defects through retinoic acid pathway disruption. This data strengthens the case for stricter hazard classifications and targeted regulatory screening of long-chain PFAS in ongoing human health risk assessments.

5 Apr 2026, 05:26pubs.acs.orgUnited States

ECHA Consults on Reproductive and Developmental Toxicity Testing for Ammonium Trivanadium Octaoxide

ECHA is consulting on reproductive and developmental toxicity testing proposals for ammonium trivanadium octaoxide, with a submission deadline of May 8, 2026. This assessment could trigger future hazard reclassifications, necessitating a review of read-across data and supply chain resilience for vanadium-based materials.

30 Mar 2026, 16:55echa.europa.euEuropean Union

ECHA Consultation on REACH Testing Proposal for Sodium Metavanadate

ECHA has launched a consultation on vertebrate testing proposals for sodium metavanadate's reproductive and developmental toxicity, closing 08 May 2026. The resulting hazard data will likely drive future CMR classifications and stricter REACH restrictions, impacting the long-term regulatory status of vanadium compounds in industrial and consumer applications.

30 Mar 2026, 16:55echa.europa.euEuropean Union

EU / ECHA Invites Information on Testing Proposal for Amides, C16-18 (Even-Numbered), N-(Hydroxyethyl) (Deadline 08 May 2026)

ECHA is seeking third-party data on REACH testing proposals for reproductive and aquatic toxicity for specific fatty acid amides through May 2026. This provides a critical window for industry to submit existing evidence to support read-across strategies and avoid the costs and ethical implications of new animal testing.

30 Mar 2026, 16:49echa.europa.euEuropean Union

EU ECHA Invites Information On REACH Testing Proposals For Amides, C8-18 (Even Numbered) And C18-Unsatd., N,N-Bis(hydroxyethyl)

ECHA is consulting on vertebrate testing proposals for a specific amide substance (EC 931-329-6) under REACH, with submissions due by 8 May 2026. Stakeholders should review existing data to potentially avoid new animal testing and prepare for hazard reclassifications that may impact downstream product compliance.

30 Mar 2026, 16:49echa.europa.euEuropean Union

EU ECHA Opens Consultation on Reproductive and Developmental Toxicity Testing Proposal for Amides, C8-18 (Even Numbered) and C18-Unsatd., N-(Hydroxyethyl) (EC 931-330-1)

ECHA has opened a consultation on higher-tier toxicity testing proposals for specific fatty acid amides, with submissions due by May 8, 2026. This process signals potential future CMR classifications, requiring manufacturers to validate read-across strategies and assess long-term substance viability in product formulations.

30 Mar 2026, 16:49echa.europa.euEuropean Union

EU/ECHA Opens Consultation On REACH Testing Proposal For Divanadium Tris(sulphate)

ECHA is seeking industry data on reproductive and developmental toxicity for Divanadium tris(sulphate) through May 8, 2026. This regulatory scrutiny may lead to future CMR classifications, potentially triggering stricter market access restrictions and hazard communication requirements for vanadium-containing products.

30 Mar 2026, 16:49echa.europa.euEuropean Union

EU/ECHA Consultation On REACH Developmental Toxicity Test Proposal For Fatty Acids, Tall-Oil, Reaction Products With Formaldehyde And (Z)-N-9-Octadecenyl-1,3-Propanediamine (CAS 68911-83-1)

ECHA is seeking third-party data on developmental toxicity for a specific tall-oil fatty acid derivative to evaluate a REACH vertebrate testing proposal by May 2026. Companies should assess their data holdings to avoid redundant testing costs and anticipate potential shifts in hazard classification for this substance.

30 Mar 2026, 16:48echa.europa.euEuropean Union

EU ECHA Invites Comments On Reproductive And Developmental Toxicity Testing Proposal For Isostearic Acid Monoisopropanolamide

ECHA is consulting on REACH testing proposals for reproductive and developmental toxicity for Isostearic acid monoisopropanolamide until May 8, 2026. Stakeholders should review existing data to mitigate animal testing requirements and prepare for potential hazard classifications that may impact downstream product compliance.

30 Mar 2026, 16:48echa.europa.euEuropean Union

ECHA Invites Comments On REACH Testing Proposal For Vanadium Dioxide (Deadline 08 May 2026)

ECHA is consulting on REACH testing proposals for vanadium dioxide's inhalation and reproductive toxicity endpoints through May 8, 2026. Companies should evaluate existing data to mitigate animal testing requirements and anticipate potential hazard reclassifications for vanadium-based materials.

30 Mar 2026, 16:48echa.europa.euEuropean Union

EU ECHA Consults on REACH Testing Proposal for Residues (Petroleum), Thermal Cracked Vacuum

ECHA is consulting on REACH testing proposals for reproductive and developmental toxicity for petroleum residues through May 8, 2026. The outcome may trigger hazard reclassifications for petroleum-derived UVCBs, necessitating a review of read-across strategies and potential supply chain impacts.

30 Mar 2026, 16:47echa.europa.euEuropean Union

EU/ECHA Testing Proposal Consultation for Residues (Petroleum), Vacuum (EC 265-057-8)

ECHA has opened a public consultation on REACH testing proposals for petroleum residues, seeking data on reproductive and developmental toxicity by May 2026. This signals potential future hazard classification changes; stakeholders should review read-across strategies to mitigate data gaps and influence the final assessment.

30 Mar 2026, 16:47echa.europa.euEuropean Union

EU ECHA Testing Proposal For Triaqua(oxalato-O,O)oxovanadium(IV) Reproductive and Developmental Toxicity (Deadline 08 May 2026)

ECHA has launched a public consultation on reproductive and developmental toxicity testing proposals for Triaqua(oxalato-O,O)oxovanadium(IV), with a submission deadline of May 8, 2026. Companies should evaluate existing data to mitigate the risk of new animal testing requirements and prepare for potential downstream hazard classifications for vanadium-based compounds.

30 Mar 2026, 16:47echa.europa.euEuropean Union

ECHA Testing Proposal Consultation On Amides, C16-18 (Even-Numbered), N-(Hydroxyethyl) (Deadline 8 May 2026)

ECHA has opened a consultation on testing proposals for Amides, C16-18 (even-numbered), N-(hydroxyethyl), requiring existing data submissions by 8 May 2026. Potential findings on reproductive and developmental toxicity could lead to stricter hazard classifications and future restrictions, necessitating early supply chain impact assessments.

30 Mar 2026, 16:46echa.europa.euEuropean Union

ECHA Consults On REACH Testing Proposal For Amides, C8-18 (even numbered) And C18-unsatd., N,N-bis(hydroxyethyl)

ECHA has initiated a consultation on REACH testing proposals for specific amides (EC 931-329-6) regarding reproductive and developmental toxicity, closing May 8, 2026. The resulting data may lead to new hazard classifications, potentially triggering stricter regulatory controls and necessitating proactive supply chain risk assessments for impacted product lines.

30 Mar 2026, 16:45echa.europa.euEuropean Union

EU ECHA Testing Proposal For Fatty Acids, Tall-Oil, Reaction Products With Formaldehyde And (Z)-N-9-Octadecenyl-1,3-Propanediamine

ECHA has initiated a public consultation on a REACH testing proposal for a fatty acid derivative (EC 272-789-1) to address developmental toxicity data gaps. Impacted manufacturers and downstream users should submit existing data by May 8, 2026, to avoid mandatory vertebrate testing and prepare for potential hazard reclassification.

30 Mar 2026, 16:43echa.europa.euEuropean Union

EFSA Develops Adverse Outcome Pathway Network for Reproductive Toxicity to Support Endocrine Disruptor Identification

EFSA published a new toxicological framework in March 2026 to standardize endocrine disruptor identification under EU biocides and pesticides regulations. This signals a shift toward mechanistic data and New Approach Methodologies (NAMs), increasing the technical requirements for demonstrating substance safety in reproductive toxicity assessments.

28 Mar 2026, 17:02efsa.europa.euEuropean Union

Canada Adds 2-Ethylhexyl 2-Ethylhexanoate to Part 2 of Schedule 1 to CEPA 1999 (SOR/2026-47)

Canada added 2-ethylhexyl 2-ethylhexanoate to Part 2 of Schedule 1 of CEPA as a toxic substance on March 13, 2026. This designation mandates the development of future risk management instruments prioritizing pollution prevention, signaling potential upcoming restrictions for manufacturers and importers.

27 Mar 2026, 18:32gazette.gc.caCanada

Exposure to PFAS and Inflammatory Bowel Disease: Review and Meta-Analysis

A March 2026 peer-reviewed meta-analysis links PFOA exposure to increased inflammatory bowel disease risk and identifies PFDA as a significant regulatory gap in US drinking water standards. This emerging epidemiological evidence increases the likelihood of expanded federal PFAS restrictions and may bolster future litigation and hazard-based classification efforts.

27 Mar 2026, 17:13nature.comUnited States

Minnesota HF 4731 Proposes Health Department Report On Lead-Containing Bullets Retained In The Body

Minnesota has introduced legislation (HF 4731) requiring a health department report by January 2027 on the long-term medical and toxicological impacts of lead ammunition fragments. While currently a reporting mandate, the study's recommendations are expected to drive future policy aimed at restricting lead-based ammunition or implementing new consumer safety disclosures.

27 Mar 2026, 07:57revisor.mn.govUnited States